August 29, 2025 a 08:00 am
BAX: Fundamental Ratio Analysis - Baxter International Inc.
Baxter International Inc. operates within the healthcare sector, providing crucial products globally. The stock is a stable presence in the market, known for its wide range of medical supplies and services. This analysis delves into its current financial standing, assessing both strengths and potential areas of improvement.
Fundamental Rating
Baxter International Inc. currently has a fundamental rating of "C-". The ratings across various financial metrics show mixed results, indicating specific areas where the company has strong financial health, as well as others where attention is needed.
| Category | Score | Score Visualization |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 1 | |
| Return on Assets | 1 | |
| Debt to Equity | 1 | |
| Price to Earnings | 1 | |
| Price to Book | 1 |
Historical Rating
The historical ratings show minimal changes in fundamental scores over the recent period, indicating stability but also a lack of significant improvement over time.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-08-28 | 1 | 4 | 1 | 1 | 1 | 1 | 1 |
| Previous | 0 | 4 | 1 | 1 | 1 | 1 | 1 |
Analysts Price Targets
Analysts have set a median price target of $30, with a high estimate of $36 and a low estimate of $24. The consensus rating suggests holding the stock, given the current market outlook.
| High | Low | Median | Consensus |
|---|---|---|---|
| $36 | $24 | $30 | Hold |
Analysts Sentiment
The majority of analysts recommend holding the stock, with a notable number favoring a buy position.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 15 | |
| Hold | 20 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
Baxter International Inc. presents a mixed financial picture with some metrics indicating strength, particularly in discounted cash flow. However, other indicators like return on equity and assets suggest areas for improvement. While the analysts' consensus is to hold the stock, investors should weigh the potential for stable, long-term growth against the need for improvements in financial metrics. Overall, the stock represents a balanced outlook with moderate expectations for future performance.